CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 58 filers reported holding CIDARA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,320,000 | -15.4% | 300,000 | 0.0% | 0.05% | -20.0% |
| Q2 2018 | $1,560,000 | +30.0% | 300,000 | 0.0% | 0.06% | +17.6% |
| Q1 2018 | $1,200,000 | -41.2% | 300,000 | 0.0% | 0.05% | -45.2% |
| Q4 2017 | $2,040,000 | -16.0% | 300,000 | 0.0% | 0.09% | -17.0% |
| Q3 2017 | $2,430,000 | +8.0% | 300,000 | 0.0% | 0.11% | -1.8% |
| Q2 2017 | $2,250,000 | -3.8% | 300,000 | 0.0% | 0.11% | -15.6% |
| Q1 2017 | $2,340,000 | -25.0% | 300,000 | 0.0% | 0.14% | -35.4% |
| Q4 2016 | $3,120,000 | +9.0% | 300,000 | +20.0% | 0.21% | +16.8% |
| Q3 2016 | $2,863,000 | +11.1% | 250,000 | 0.0% | 0.18% | -6.3% |
| Q2 2016 | $2,578,000 | -18.8% | 250,000 | 0.0% | 0.19% | -28.2% |
| Q1 2016 | $3,175,000 | -26.0% | 250,000 | 0.0% | 0.27% | -18.2% |
| Q4 2015 | $4,290,000 | +22.6% | 250,000 | -9.1% | 0.32% | +14.4% |
| Q3 2015 | $3,498,000 | -0.2% | 275,000 | +10.0% | 0.28% | +10.9% |
| Q2 2015 | $3,505,000 | – | 250,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,163,631 | $3,095,000 | 1.89% |
| 5AM Venture Management, LLC | 2,006,511 | $5,337,000 | 0.96% |
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,609,000 | 0.95% |
| Omega Fund Management, LLC | 2,005,249 | $5,334,000 | 0.50% |
| KNOTT DAVID M | 415,308 | $1,105,000 | 0.47% |
| BVF INC/IL | 3,739,704 | $9,948,000 | 0.37% |
| West Family Investments, Inc. | 368,910 | $981,000 | 0.36% |
| Monashee Investment Management LLC | 369,099 | $982,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 178,732 | $475,000 | 0.08% |
| JEPPSON WEALTH MANAGEMENT, LLC | 47,550 | $126,000 | 0.08% |